Drugs that block enzymes called tyrosine kinases are among the most effective targeted therapies for cancer. However, they ...
The Print on MSN
MIT study answers why some cancer treatments fail. Most tumours have active backdoor pathways
Some cancer treatments fail not because the drugs were ineffective, but because tumours design a network to evade them.
A new study conducted by researchers from the University of Potsdam and the University of Cologne has deciphered the ...
Today's nearly $70 billion U.S. biofuels economy is powered by two technology toolboxes. Biochemical technologies—used to produce around 17 billion gallons of ethanol annually—leverage microorganisms ...
In a bid to better understand, and potentially treat, a host of conditions that affect early cognition, neurodevelopment, and ...
In a bid to better understand, and potentially treat, a host of conditions that affect early cognition, neurodevelopment and ...
Gut microbiome changes may drive age-related memory loss via inflammation and disrupted brain signaling, but interventions in mice show this process can be reversed.
A little change in the cycle that produces hair could tip the scales toward either healthy, continued hair growth or slow, ...
The post HYD Pioneers New Research Revealing Systemic Role of Deuterium-Depleted Water in Cancer Therapy appeared first on ...
A recent study published in the International Journal of Molecular Sciences explores how deuterium concentration, an ...
Researchers have uncovered an early survival response in ovarian cancer cells that may limit the effectiveness of widely used ...
Researchers have discovered a way to slow the progression of Huntington's disease by blocking SLC4A7 proteins that form neural connections.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results